论文成果
- 24、 RRx-001 ameliorates inflammatory diseases by acting as a potent covalent NLRP3 inhibitor. Y Chen, H He, B Lin, Y Chen, X Deng, W Jiang, R Zhou,Cellular & molecular immunology,2021,
- 23、 GPR34-mediated sensing of lysophosphatidylserine released by apoptotic neutrophils activates type 3 innate lymphoid cells to mediate tissue repair. X Wang, J Cai, B Lin, M Ma, Y Tao, Y Zhou, L Bai, W Jiang, R Zhou,Immunity,2021,
- 22、 Golgi apparatus: an emerging platform for innate immunity. Y Tao, Y Yang, R Zhou, T Gong,Trends in cell biology,2020,
- 21、 Myeloid PTEN promotes chemotherapy-induced NLRP3-inflammasome activation and antitumour immunity. Yi Huang, Huanyu Wang, Yize Hao, Hualong Lin, Menghao Dong, Jin Ye, Lei Song, Yunzhi Wang, Qingqing Li, Benjie Shan, Yizhou Jiang, Hongqi Li, Zhiming Shao, Guido Kroemer, Huafeng Zhang, Li Bai, Tengchuan Jin, Chao Wang, Yuting Ma, Yongping Cai, Chen Ding, Suling Liu, Yueyin Pan, Wei Jiang, Rongbin Zhou,Nature Cell Biology,2020,
- 20、 DAMP-sensing receptors in sterile inflammation and inflammatory diseases. T Gong, L Liu, W Jiang, R Zhou,Nature Reviews Immunology,2020,
- 19、 ApoC3: an ‘alarmin’triggering sterile inflammation. T Gong, R Zhou,Nature Immunology,2020,
- 18、 Commensal viruses maintain intestinal intraepithelial lymphocytes via noncanonical RIG-I signaling. L Liu, T Gong, W Tao, B Lin, C Li, X Zheng, S Zhu, W Jiang, R Zhou,Nature Immunolog,2019,
- 17、 The strategies of targeting the NLRP3 inflammasome to treat inflammatory diseases. H Jiang, T Gong, R Zhou,Advances in immunology,2019,
- 16、 Control of inflammasome activation by phosphorylation. T Gong, W Jiang, R Zhou,Trends in biochemical sciences,2018,
- 15、 GPCRs in NLRP3 inflammasome activation, regulation, and therapeutics. T Tang, T Gong, W Jiang, R Zhou,Trends in pharmacological sciences,2018,
